Pacira Pharmaceuticals Inc., a San Diego–based maker of controlled-release injectable products, has expanded its Series A round to $85 million, according to a regulatory filing. It had previously secured approximately $30 million. Backers include MPM Capital, HBM BioVentures, OrbiMed Advisors and Sanderling Ventures. www.pacira.com
